Back to search

Article

Exploring Resistance to ETS Targeting Agents in Diffuse Large B-Cell Lymphoma

2025-09-20

Abstract excerpt

Diffuse large B-cell lymphoma (DLBCL) remains a challenging disease with limited therapeutic options beyond standard immunochemotherapy. ETS transcription factors, including SPIB and SPI1, are implicated in lymphoma pathogenesis and can be targeted by the small molecule TK216, which disrupts ETS-DHX9 interactions. To explore mechanisms of resistance, we generated stable TK216-resistant clones from the ABC-DLBCL li...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1b2a3bfd-b784-5654-9169-514703d53164
DOI
10.1101/2025.09.18.675797
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring Resistance to ETS Targeting Agents in Diffuse Large B-Cell LymphomaDOI 10.1101/2025.09.18.675797
Select a neighboring publication to make it the new centre.